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Abstract 
Background: Antimicrobial stewardship has been associated with a reduction in the 
incidence of health care associated Clostridium difficile infection (HA-CDI). However, 
CDI remains under-recognized in many low and middle-income countries where clinical 
and surveillance resources required to identify HA-CDI are often lacking. The rate of 
toxigenic C. difficile stool positivity in the stool of hospitalized patients may offer an 
alternative metric for these settings, but its utlity remains largely untested. 
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Aim/Objective: To examine the impact of an antimicrobial stewardship on the rate of 
toxigenic C. difficile positivity among hospitalized patients presenting with diarrhoea 
Methods: A 12-year retrospective review of laboratory data was conducted to compare 
the rates of toxigenic C. difficile in diarrhoea stool of patients in a hospital in Saudi 
Arabia, before and after implementation of an antimicrobial stewardship program  
Result: There was a significant decline in the rate of toxigenic C difficile positivity from 
9.8 to 7.4% following the implementation of the antimicrobial stewardship program, and 
a reversal of a rising trend. 
Discussion: The rate of toxigenic C. difficile positivity may be a useful patient outcome 
metric for evaluating the long term impact of antimicrobial stewardship on CDI, 
especially in settings with limited surveillance resources. The accuracy of this metric is 
however dependent on the avoidance of arbitrary repeated testing of a patient for cure, 
and testing only unformed or diarrhoea stool specimens. Further studies are required 
within and beyond Saudi Arabia to examine the utility of this metric. 
 
Background 
Clostridioides difficile infection (CDI) is caused by toxigenic strains of C. difficile (tCd), a 
Gram-positive, spore forming, antibiotic-resistant anaerobic bacillus. CDI is considered 
to be the most common cause of diarrhoea in healthcare settings in Europe and North 
America, and an urgent antimicrobial resistance threat (CDC, 2019). 
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Most of what is known of the impact of antimicrobial stewardship on CDI has emerged 
from studies in North America and Europe. Systematic reviews indicate that the incidence 
of healthcare-associated CDI (HA-CDI) is the metric most often utilized in these studies 
(Feazel et al 2014, Baur et al 2017). 
Other studies (Talpaert et al 2011, Jump et al 2012, Lawes et al 2017) have measured 
the rate of tCd positivity in diarrhoea stool as a proxy for CDI, and observed a reduction 
following the implementation of antimicrobial stewardship interventions. This is a simpler 
metric than the incidence of HA-CDI because it does not require clinical diagnosis of CDI, 
and does not distinguish between hospital and community-acquired CDI. It may therefore 
find broader applicability in settings lacking the level of surveillance and diagnostic 
capacity required to identify HA-CDI. A potential drawback however is that the rate of tCd 
positivity in a hospital setting may be inflated by a high level of asymptomatic tCd carriers 
in the catchment population, thereby obscuring the true impact of hospital-based 
stewardship interventions. 
In Saudi Arabia, the few available CDI studies (Al-Tawfiq and Abed 2010, Alzaharani and 
Al Johani 2013, Hudhaiah and Elhadi 2019) suggest that the prevalence in Saudi 
communities may be under-estimated, due to a combination of low diagnostic suspicion 
and resources. This assertion is supported by Saudi studies on self-medication (non-
prescription use) with antibiotics (Al-Mohamadi et al 2013, Alshammari et al 2017, Bin 
Nafisah et al 2017, Alhomoud et al 2018) that highlight unregulated and inappropriate 
population exposure to antibiotics, an important risk factor for tCd/CDI.  
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The true burden of tCd in Saudi communities remains unknown however, and the extent 
to which this limits the utility of tCd positivity as a metric of hospital antimicrobial 
stewardship is uncertain. Given these uncertainties, we decided to compare the period 
positivity rate of tCd in diarrhoea stool obtained from in-patients before and after the 
implementation of a hospital antimicrobial stewardship program in Saudi Arabia.  
METHODS 
Setting 
Johns Hopkins Aramco Healthcare (JHAH) is a 5-site healthcare facility in the Eastern 
province of Saudi Arabia. The study setting, Dhahran health centre (DHC) is the largest 
hospital of JHAH. Services include general medicine and surgery, intensive care, and 
management of haematological and solid organ malignancies. The hospital serves a 
catchment population of approximately 370,000 patients. 
Study Design 
This was retrospective study covering a twelve-year period. The study compared the rate 
of tCd positivity among in-patients at JHAH, in the six year intervals before and after 
implementation of the antimicrobial stewardship program (ASP). The study was approved 
by the Institutional Research Board of JHAH. 
The ASP was formally launched in 2011, starting with education sessions specifically 
targeted at prescribers and hospital pharmacists (Table 1). This was preceded in 2010 
however, by the introduction of restricted laboratory reporting of antibiotic  
All rights reserved. No reuse allowed without permission. 
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for this preprintthis version posted February 24, 2021. ; https://doi.org/10.1101/2021.02.23.21252226doi: medRxiv preprint 
5 
 
Table 1 JHAH Antimicrobial Stewardship Interventions 
Intervention Date of Implementation 
Prescriber and Pharmacist Education sessions 2011 
Automatic Renal Dosing 2012 
Antibiotic De-escalation protocol 2012 
Intravenous to Oral Conversion Program; 2012 
Vancomycin Pharmacokinetic monitoring 2012 
Peril-operative antibiotic protocols using adapted orders 2012 
Multiple interventions including prospective audits, and 
feedback to prescribers in paediatric outpatient clinics to 




susceptibilities for selected Gram negative organisms (Al-Tawfiq et al, 2015). Other 
program components were introduced in 2012. These were automatic renal dosing, an 
antibiotic de-escalation protocol, intravenous to oral conversion program, vancomycin 
pharmacokinetic monitoring, pre-operative antibiotic protocol/adapted orders and 
multiple interventions including prospective audit and feedback paediatric outpatient 
clinics to improve prescribing practices for upper respiratory tract infections in paediatric 
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outpatient clinics (Al-Tawfiq and Alawami 2017). The antimicrobial stewardship program 
was led by an infection disease physician and pharmacist. 
Outcome 
The rates of tCd positivity before and after the implementation of the ASP were 
estimated by dividing the number of tCd positive patients by the total number of patients 
tested in each period. Duplicate positive tests were excluded for each patient, except 
when a second positive test was obtained more than 8 weeks after the first, in which 
case it was considered a new infection and included in the positivity estimate.  
The age group categories used were elderly (65 years and above), adult (18 to 64 years) 
and paediatric (3-17 years). Paediatric patients below the age of 3 were excluded from 
the study due to the propensity of the 0-2 age group for asymptomatic colonization with 
toxigenic and non-toxigenic C. difficile strains (American Academy of Paediatrics, 2013, 




The C. difficile  policy in the study setting is to test only loose or watery stool (stool 
conforming to the shape of the container). Criteria for sending diarrhea or loose stool 
specimens to the laboratory for C.difficile testing are: 3 or more loose/watery bowel 
movements in a 24 hour period, bowel movements unusual or different for the patient, 
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no other recognized aetiology for the diarrhea (e.g. laxative use, inflammatory bowel 
disease).  
Over the study period, stool specimens were tested for C. difficile toxins A and B using 
Enzyme-linked immunosorbent assay (Premier Toxins A&B EIA; Meridian Bioscience). 
Test results and anonymised demographic data ( patients’ age, gender, and in-patient 
location at the time of specimen collection) were received from the laboratory.  
Definitions 
A case of CDI was defined as a patient with a positive tCd test. Recurrent CDI (relapse)  
was defined as patient positive for tCd 2-8 weeks after the initial positive test. 
Re-infection was defined as patient positive for tCd more than 8 weeks after the initial 
positive test (CDC/McDonald et al 2007, Cohen et al 2010). 
Age-group-specific tCd positivity was obtained by expressing the number of tCd positive 
patients in a specific age group as a proportion of the number of patients tested in that 
group. 
Statistical Analysis 
Data was analysed using SPSS version 23 (SPSS Inc., Chicago, IL) for Windows. The 
Fisher exact test was used to test for differences in proportions. The Student t-test was 
used to compare the means of continuous variables. Two-sided P values less than 0.05 
were considered statistically significant. 
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RESULTS 
Over the study period (2005 to 2016), a total of 3086 inpatients at Johns Hopkins Aramco 
hospital (JHAH) were tested for tCd. 260 patients tested positive for tCd, giving an overall 
period positivity rate of 8.4%.  
The mean age of the study population and tCd positive patients was 55 and 59 
respectively. The majority (143/260; 55%) of tCd positive patients were elderly (65 years 
and over), although this age group comprised just over 40% of patients tested for tCd 
over the study period 
A total of 12/260 patient were identified with a repeat tCd positive test more than 8 weeks 
after the first positive test. In keeping with the study case definition (CDC/McDonald et al 
2007),  these were considered new cases of CDI (re-infections) and included in the period 
positivity estimate. The majority of re-infections  (8/12; 66%) were observed among the 
elderly. A total of 28/260 patients were identified with tCd 2-8 weeks after the initial 
positive test. These were considered relapses rather than new cases of CDI and excluded 
from the positivity estimate. The majority (18/28; 64%) of relapses were observed in the 
elderly. 
The upward trend in tCd positivity observed in the six-year period prior to the 
implementation of antimicrobial stewardship was reversed in the six-year period following 
the implementation of the program (figure 1). Overall, there was a significant decline 
(p=0.022) in tCd positivity from 9.8% (129/1318) to 7.4% (131/1768) pre and post ASP 
respectively.  
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Figure 1. Secular trend in tCd positivity pre and post ASP 
The decline in tCd positivity was observed in all three age groups, but this was statistically 
significant (p<0.05) only among paediatric patients (table 2 and figure 2). 
 
Table 2 Age group-specific tCd positivity pre and post ASP 
 



















Elderly 548 64 11.7 775 79 10.2 .419 
Adult 613 48 7.8 821 48 5.8 .084 
Paediatric 157 17 10.8 172 4 2.3 .002 
Total 1318 129 9.8 1768 131 7.4 .022 
 



























All rights reserved. No reuse allowed without permission. 
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for this preprintthis version posted February 24, 2021. ; https://doi.org/10.1101/2021.02.23.21252226doi: medRxiv preprint 
10 
 
Figure 2.  Age group-specific tCd positivity pre and post ASP 
*Significant decline (p<0.05) 
There were no significant differences in tCd positivity by gender, with females accounting 
for 139/260 (53%) and males 121/260 (47%) of the tCd positive patients identified.  
DISCUSSION 
Unlike North America and Europe from where the majority of studies on CDI epidemiology 
have emerged, Saudi Arabia has a predominantly young population (<65 years), with the 
elderly (≥65 years) accounting for less than 5% of the population (United Nations, World 
Population Prospects, 2019) .  Therefore the predominance of the younger age groups 
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demographic distribution. The age-group distribution of tCd positive patients observed in 
the current study is also consistent with North American and European studies (McDonald 
et al 2006, Khanna et al 2012, Pechal et al 2016) that identify the elderly as being at 
especially high risk for CDI.  
Although the post-ASP decline in tCd positivity was observed in all three age groups, this 
was statistically significant only among paediatric patients. The reason for this outcome 
is uncertain, but may be related to the excess burden among older patients of other CDI 
risk factors, including clinical co-morbidities and exposure to proton pump inhibitors and 
histamine 2 (h2) antagonists (Kwok et al 2012, Rotman and Bishop 2013, Seto et al 2014) 
The outcome may also reflect a higher level of compliance with antimicrobial stewardship 
recommendations among paediatricians, although there is no evidence in the current 
study to support this. 
In a systematic review, Feazel et al (2014) observed that studies reporting the most 
impact of antimicrobial stewardship on CDI were those conducted in elderly settings, and 
pre-authorization of antibiotics and formulary restriction a part of the program. Therefore, 
a plausible explanation for the non-significant impact of the ASP on tCd positivity among 
the elderly in the current study is that this high-risk group was not specifically targeted for 
intervention. Furthermore, the ASP consisted primarily of persuasive interventions, and 
did not involve restriction of antibiotics. This meant that prescribers, largely, maintained 
autonomy and were not obliged to comply with stewardship recommendations.  
The impact of the ASP on tCd positivity among elderly and adult patients may also have 
been dampened by the outbreak of MERS coV that occurred at the study setting in 2013, 
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during the post-ASP period. MERS coV disproportionately affected these age groups (Al-
Tawfiq et al 2014), and was associated with an increase in empiric and prophylactic 
antibiotic use (Momattin et al 2018). This may have contributed to the reversal in 2014 of 
the downward trend in tCd observed in the post-ASP period (figure 2) 
Despite these drawbacks, the ASP was associated with a significant overall decline in 
tCd positivity. Perhaps, support of the program by an infectious disease (ID) physician 
played a vital role in influencing antibiotic prescribing practices, and contributed to the 
observed effect. This assertion is consistent with other CDI studies (Jump et al 2012, 
Tedeschi et al 2017, Ostrowsky et al 2018) highlighting the impact of ID physician support 
in antimicrobial stewardship, either alone, or in combination with other interventions. .  
The retrospective, before-and-after intervention study design limits the extent to which 
the observed outcome can be attributed solely to the ASP. The influence of other related 
interventions implemented before the ASP, that were on going over the study period 
cannot be discounted. These include the hand hygiene program, and the promotion of 
infection prevention and environmental services best practices for CDI. It is noteworthy 
however, that these interventions were in place prior to the ASP, and the rising trend in 
tCd period positivity was reversed only after the implementation of the program in 2011. 
Life expectancy has increased in Saudi Arabia, and a more than 3-fold increase in the 
proportion of the elderly is projected over the next two decades (United Nations, World 
Population Prospects 2019). With this demographic shift, the prevalence of CDI is likely 
to increase. To mitigate this, there is a need for concerted efforts to implement 
antimicrobial stewardship in health care settings, and regulate population access to 
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antibiotics. Periodic measurements of in-patient tCd positivity may offer a useful means 
of monitoring the impact of hospital antimicrobial stewardship programs, especially in 
those settings lacking the resources to accurately measure the rate of HA-CDI. The 
accuracy of this metric is however reliant on consistent best practices among clinicians 
and laboratory personnel. These include the avoidance of arbitrary repeated testing of a 
patient for cure, and testing only unformed or diarrhoea stool specimens. This will improve 
efficiency, reduce bias, and enhance the predictive value of a positive tCd test. Further 
studies are required within and beyond Saudi Arabia to examine the utility of this metric. 
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